GlassScriptPhysician profile
Benjamin M Thomas
NPI 1831391945
$5,208.12
in general payments reported to CMS, 2019-2025
48 companies · $915 in 2025
The $915 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,537 · 2020: $772 · 2021: $169 · 2022: $269 · 2023: $562 · 2024: $984 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,461.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $544.56 | 2019-2025 | Qulipta, Botox, Ubrelvy |
| Novartis Pharmaceuticals Corporation | $492.77 | 2019-2025 | |
| Pfizer INC. | $391.97 | 2023-2025 | |
| Sunovion Pharmaceuticals INC. | $293.54 | 2019-2022 | |
| Csl Behring | $281.09 | 2022-2025 | Kcentra, Hizentra |
| Teva Pharmaceuticals USA, INC. | $274.37 | 2019-2024 | Austedo Xr |
| Acadia Pharmaceuticals INC | $226.63 | 2019-2025 | Nuplazid |
| Amneal Pharmaceuticals LLC | $201.71 | 2019-2023 | Rytary |
| Microtransponder, INC. | $190.31 | 2024 | |
| Argenx US, INC. | $182.36 | 2023-2025 | Vyvgart Hytrulo |
| Ucb, INC. | $166.52 | 2019-2024 | Rystiggo, Briviact, Zilbrysq |
| Genentech USA, INC. | $153.88 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
| Allergan, INC. | $152.91 | 2019-2020 | |
| Amgen INC. | $143.32 | 2019-2023 | Aimovig |
| Emd Serono, INC. | $130.93 | 2019-2024 |
Show all 46 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.